Out of stock

This item is currently unavailable

Gone for 77 days. Could come back at any time — we're watching for you.

Out of stock 77 days

World Outlook for Pneumonia Therapeutics 2025-2030 Study

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

View at Amazon ↗
Out of stock

Price data last checked 77 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

No price data available for histogram

Description

Gain a comprehensive understanding of the global pneumonia therapeutics market with this detailed economic study. Covering more than 190 countries, the report provides essential data for market analysis and strategic planning through the year 2030. Each year of the forecast includes estimates for latent demand, also referred to as potential industry earnings (P.I.E.), expressed in millions of U.S. dollars. By providing the percent share for each country relative to its specific region and the global market, this study offers comparative benchmarks to help you evaluate individual country performance against others. The data is built using econometric models that project fundamental economic dynamics both within and across different nations, making it a valuable resource for understanding global market shifts.

Key Features

Provides a global outlook for pneumonia therapeutics spanning from 2025 to 2030.

Covers market data and analysis for more than 190 different countries.

Includes estimates for latent demand and potential industry earnings (P.I.E.) in millions of U.S. dollars.

Delivers comparative benchmarks by showing each country's percent share of its region and the global market.

Utilizes econometric models to project fundamental economic dynamics for accurate country-level estimates.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
06 May 2024

Similar Products You Might Like

The 2023-2028 Outlook for Pneumonia Therapeutic Drugs in the United States
99% match

The 2023-2028 Outlook for Pneumonia Therapeutic Drugs in the United States

£520.00 03 Oct 2026
World Outlook for Pneumatic Compression Therapies 2025-2030
96% match

World Outlook for Pneumatic Compression Therapies 2025-2030

Price unavailable
World Outlook for Pneumococcal Vaccines 2025-2030 Book
96% match

World Outlook for Pneumococcal Vaccines 2025-2030 Book

Price unavailable
Swine Respiratory Diseases Treatments World Outlook 2025-2030
96% match

Swine Respiratory Diseases Treatments World Outlook 2025-2030

Price unavailable
World Outlook for Interventional Pulmonology 2025-2030
96% match

World Outlook for Interventional Pulmonology 2025-2030

Price unavailable
Pneumococcal Vaccines in India Outlook 2023-2028 Report
96% match

Pneumococcal Vaccines in India Outlook 2023-2028 Report

£515.00 31 Oct 2026
World Outlook for Pulmonary Fibrosis Treatments 2025-2030
96% match

World Outlook for Pulmonary Fibrosis Treatments 2025-2030

Price unavailable
US Pneumococcal Vaccines Outlook 2023-2028 Study Report
96% match

US Pneumococcal Vaccines Outlook 2023-2028 Study Report

£520.00 28 Oct 2026
The 2023-2028 World Outlook for Pulmonary Fibrosis Treatments
96% match

The 2023-2028 World Outlook for Pulmonary Fibrosis Treatments

Price unavailable
World Outlook for Idiopathic Pulmonary Fibrosis Treatments
96% match

World Outlook for Idiopathic Pulmonary Fibrosis Treatments

£790.00 05 Nov 2026
The 2023-2028 Outlook for Pneumococcal Vaccines in China
96% match

The 2023-2028 Outlook for Pneumococcal Vaccines in China

£495.00 29 Oct 2026
The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis Treatments
96% match

The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis Treatments

Price unavailable
The 2016-2021 World Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics
96% match

The 2016-2021 World Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics

£995.00 29 Oct 2026
World Outlook for Respiratory Disorder Treatments 2025-2030
96% match

World Outlook for Respiratory Disorder Treatments 2025-2030

Price unavailable
US Respiratory Care Equipment and Supplies Outlook 2016-2021
96% match

US Respiratory Care Equipment and Supplies Outlook 2016-2021

£595.00 04 Nov 2026
The 2023-2028 World Outlook for Non-Small Cell Lung Cancers
96% match

The 2023-2028 World Outlook for Non-Small Cell Lung Cancers

Price unavailable
2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis
96% match

2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis

£790.00 05 Nov 2026
Pulmonary Fibrosis Treatment Outlook 2023-2028 - US Study
96% match

Pulmonary Fibrosis Treatment Outlook 2023-2028 - US Study

£520.00 05 Nov 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India
96% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India

£515.00 02 Sep 2026
The 2023-2028 World Outlook for Adult and Adolescent Pneumococcal Vaccines
96% match

The 2023-2028 World Outlook for Adult and Adolescent Pneumococcal Vaccines

£795.00 02 Nov 2026
The 2023-2028 Outlook for Pneumococcal Vaccines in Japan
96% match

The 2023-2028 Outlook for Pneumococcal Vaccines in Japan

£495.00 02 Nov 2026
The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis
96% match

The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis

Price unavailable
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India
96% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India

£515.00 02 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States

£520.00 02 Oct 2026